ADLINE CHEM LAB LIMITED Share Price

ADLINE CHEM LAB LIMITED Share Price

BSE: 524604
|
Pharmaceuticals
|
S Cap
₹ 14.33
+₹0.68 (4.98%)
1D
Last updated 23 Sep, 2026, 10:20 IST

ADLINE CHEM LAB LIMITED Share Price Today

As of 23 Sep 2026, ADLINE CHEM LAB LIMITED share price is ₹14.33. The stock opened at ₹14.33, compared to its previous close of ₹13.65. During today's trading session, ADLINE CHEM LAB LIMITED share price moved in the range of ₹14.33 to ₹14.33, with an average price of ₹14.33 for the day. Looking at its last 52-week, the stock has touched a low of ₹7.60 and a high of ₹17.06.

₹14.33
4.98% up today
₹14.33
1D LOW
1D HIGH

ADLINE CHEM LAB LIMITED Returns Calculator

Circuit
L
H
₹12.97
₹14.33
52-week
L
H
₹7.60
₹17.06

About ADLINE CHEM LAB LIMITED

ADLINE CHEM LAB LIMITED Share Price
ISIN
INE276T01018
Sector Market Cap
₹ 7.61 Cr

Adline Chem Lab Limited is an India-based company. The Company is engaged in the business of marketing pharmaceutical products. The Company operates in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. Its products for the international market include tablets, capsules and injections. Its veterinary products include B Complex Liver Extract with Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. It also offers educational supplements. It offers manufacturing facilities for tablets, capsules, liquid orals and small volume parentals for contract manufacturing.

ADLINE CHEM LAB LIMITED Financial Highlights

  • Revenue: ADLINE CHEM LAB LIMITED reported revenue of ₹0.01 crore in FY26 vs ₹0.25 crore in FY25. It showed a decrease of 96.00% on a yearly basis.
  • Operating Profit: ADLINE CHEM LAB LIMITED reported an operating loss of ₹0.32 crore in FY26 vs ₹0.21 crore in FY25. It showed a decrease of 52.38% on a year-on-year basis.
  • Net Profit: ADLINE CHEM LAB LIMITED reported a net loss of ₹0.28 crore in FY26 vs ₹0.13 crore in FY25. It showed a decrease of 115.38% on a yearly basis.

ADLINE CHEM LAB LIMITED Quarterly Result Highlights

  • ADLINE CHEM LAB LIMITED reported revenue of ₹0.12 crore in Jun 2026, compared with ₹0.01 crore in Mar 2026, representing an increase of 1,100.00% on a quarter-on-quarter (QoQ) basis.
  • ADLINE CHEM LAB LIMITED reported an operating profit of ₹0.03 crore in Jun 2026, compared with ₹0.11 crore in Mar 2026, representing an increase of 127.27% on a quarter-on-quarter (QoQ) basis.
  • ADLINE CHEM LAB LIMITED reported a profit of ₹0.04 crore in Jun 2026, compared with ₹0.09 crore in Mar 2026, reflecting an increase of 144.44% on a QoQ basis.
  • The earnings per share (EPS) of ADLINE CHEM LAB LIMITED stood at ₹0.48 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
25.85%
FII
0.00%
Other DII
0.00%
Retail and other
74.15%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
7.99
P/E
-42.66
P/B
-4.13
ROE
15.84%
D/E
-1.02
ROCE
-495.76%
Div. Yield
0.00%
EPS(TTM)
-0.48
Turnover
0.00
EV/EBITDA
-155.78
Net Margin
0.00%
Op. Margin
0.00%
ROA
-257.14%
Quick Ratio
3.74
Curr. Ratio
3.97
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Adline Chem Lab outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Adline Chem Lab appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ADLINE CHEM LAB LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹0.00₹0.00₹0.00₹0.00
Other Income₹0.01₹0.25₹0.00₹1.00
Total Revenue₹0.01₹0.25₹0.00₹1.00
Total Expenses₹0.33₹0.45₹0.30₹0.88
Profit Before Tax-₹0.32-₹0.21-₹0.30-₹4.23
Tax-₹0.04-₹0.07-₹0.03₹0.00
Profit After Tax-₹0.28-₹0.13-₹0.27-₹4.23
EPS - Basic-₹0.48-₹0.21-₹0.46-₹7.24
EPS - Diluted-₹0.48-₹0.21-₹0.46-₹7.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹0.32-₹0.21-₹0.30-₹4.23
Income before WC changes-₹0.17-₹0.31-₹0.18₹0.22
Change in Assets₹0.01-₹0.01₹0.00₹0.40
Change in Liabilities₹0.01-₹0.01₹0.01-₹0.60
Change in WC₹0.02-₹0.02₹0.01-₹0.20
Cash flow from Operations-₹0.16-₹0.23-₹0.17₹0.01
Cash flow from Investing₹0.00₹0.00₹0.00₹0.00
Cash flow from Financing₹0.16₹0.25₹0.15₹0.00
Total Cash Flow₹0.00₹0.02-₹0.02₹0.01
Cash (Start of the year)₹0.06₹0.04₹0.06₹0.05
Cash (End of the year)₹0.07₹0.06₹0.04₹0.06

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹0.00₹0.01₹0.00₹0.00
Current Assets₹0.07₹0.07₹0.04₹0.06
Total Assets₹0.07₹0.08₹0.04₹0.06
Current Liabilities₹0.02₹0.02₹1.38₹1.34
Net Current Asset₹0.05₹0.05-₹1.34-₹1.28
Non-Current Liabilities₹1.83₹1.55₹0.03₹0.29
Equity Capital-₹1.77-₹1.49-₹1.37-₹1.57
Total Equity & Liabilities₹0.07₹0.08₹0.04₹0.06
* All values are in INR Crore
Qty
Bid
500
14.33
100
13.5
100
13.35
100
13.25
100
12.97
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 900
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
40.86
Neutral
ATR (14)
0.49
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
40.25
Bearish
UO(9)
61.89
Neutral
ROC(12)
28.41
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
12.57
12.87
10D
12.5
12.57
20D
12.43
12.39
50D
12.03
12.43
100D
12.32
0
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ADLINE CHEM LAB LIMITED Share Price
ADLINE CHEM LAB LIMITED
Pharmaceuticals
Add Stock
Add Another

ADLINE CHEM LAB LIMITED Share Price FAQs

ADLINE CHEM LAB LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837